Vera Therapeutics, Inc. (VERA)
26.97
-1.13
(-4.02%)
USD |
NASDAQ |
Nov 16, 16:00
26.97
0.00 (0.00%)
After-Hours: 18:51
Vera Therapeutics Max Drawdown (5Y) : 84.89% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 84.89% |
| September 30, 2026 | 84.89% |
| August 31, 2026 | 84.89% |
| July 31, 2026 | 84.89% |
| June 30, 2026 | 84.89% |
| May 31, 2026 | 84.89% |
| April 30, 2026 | 84.89% |
| March 31, 2026 | 84.89% |
| February 28, 2026 | 84.89% |
| Date | Value |
|---|---|
| January 31, 2026 | 84.89% |
| December 31, 2025 | 84.89% |
| November 30, 2025 | 84.89% |
| October 31, 2025 | 84.89% |
| September 30, 2025 | 84.89% |
| August 31, 2025 | 84.89% |
| July 31, 2025 | 84.89% |
| June 30, 2025 | 84.89% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Beam Therapeutics, Inc. | 89.12% |
| Sarepta Therapeutics, Inc. | 93.33% |
| Twist Bioscience Corp. | 94.48% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -2.735 |
| Beta (5Y) | 1.066 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 106.3% |
| Historical Sharpe Ratio (5Y) | 0.0566 |
| Historical Sortino (5Y) | 0.1435 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.31% |